Table 2. Association of clinical outcomes with gene expression and select clinical variables.

Variables	Serum creatinine	MDRD GFR	Proteinuria	Graft loss	Death-censored graft loss
TNF-α	NS	NS	NS	Positive, p = 0.0524	Positive, p = 0.0315
CD25	NS	NS	NS	NS	NS
TGF-β	NS	NS	NS	NS	NS
A20	NS	NS	NS	NS	NS
Bcl-xl	NS	NS	NS	NS	NS
Bcl-2	NS	NS	NS	Negative, p = 0.0128	NS
IL-10	NS	NS	NS	NS	NS
IL-6	NS	NS	NS	NS	NS
PECAM	NS	Positive, p = 0.023	NS	NS	NS
ICAM-1	NS	NS	NS	NS	NS
Ho-1	NS	NS	NS	NS	NS
CD40	NS	NS	Negative, p = 0.0067	NS	NS
CD3	NS	Negative, p = 0.0264	NS	NS	NS
IFN-γ	NS	NS	NS	NS	NS
NF-κB	NS	NS	NS	NS	NS
Recipient race	NS	NS	NS	NS	NS
Donor race	NS	NS	NS	NS	NS
Transplant number (first, second, third)	NS	NS	NS	NS	NS
Donor type (living or deceased)	NS	NS	NS	NS	NS
Recipient age	NS	NS	NS	NS	NS
Donor age	Positive, p = 0.0412	Negative, p = 0.0499	NS	NS	NS
Warm ischemia time	NS	NS	NS	NS	NS
Cold ischemia time	NS	NS	NS	NS	NS
HLA match	NS	NS	NS	NS	NS
Delayed graft function	NS	NS	NS	NS	NS
Acute rejection	Positive, p = 0.0279	NS	Positive, p = 0.0074	NS	NS
Induction therapy with depleting agent	NS	NS	NS	NS	NS
Diabetes in the recipient	NS	NS	NS	NS	NS
Triglyceride level	NS	NS	NS	NS	NS
Systolic blood pressure	NS	NS	NS	NS	NS
Diastolic blood pressure	NS	NS	NS	NS	NS
Immunosuppressive drug level	NS	NS	NS	NS	NS
Sirolimus use	NS	NS	NS	NS	NS

NS, not significant.